ArticleBriefings in bioinformatics2025
GCNMF-SDA: predicting snoRNA-disease associations based on graph convolution and non-negative matrix factorization.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Small nucleolar RNAs (snoRNAs) play crucial roles in a wide range of biological processes, and studying their association with diseases can enhance our understanding of disease pathogenesis. Nevertheless, current knowledge of these associations is limited traditional biological experiments are both costly and time-consuming. Consequently, developing efficient computational methods is essential for predicting potential snoRNA-disease associations. We propose a novel prediction method based on non-negative matrix factorization and graph convolution for predicting snoRNA-disease associations (GCNMF-SDA). First, five different types of similarity information from snoRNA and disease entities are introduced to fully mine and refine the feature information. Then the snoRNA and disease similarity networks are integrated using nonlinearity approach Similarity Network Fusion (SNF), while the weighted K nearest known neighbors (WKNKN) algorithm is applied to optimize the snoRNA-disease association matrix. Following this, the graph convolution module and the non-negative matrix factorization module extract disease features and snoRNA features, respectively. After extracting these features, they are combined into a composite feature vector for each snoRNA-disease pair. Finally, the composite feature vectors along with their corresponding labels, are input into a multilayer perceptron for training. Our experiments, conducted using a rigorous five-fold cross-validation approach, reveal that the GCNMF-SDA model achieves an impressive area under the receiver operating characteristic curve (AUC-ROC) of 0.9659 and an area under the precision-recall curve (AUC-PR) of 0.9522. Furthermore, most of the novel associations identified by GCNMF-SDA were validated through case studies, underscoring the method's reliability in predicting potential relationships between snoRNAs and diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.